Peter Kraass

Title: Peter Kraass: Innovator in Pharmaceutical Composition

Introduction

Peter Kraass is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance the efficacy and stability of medications. With a total of 2 patents to his name, Kraass continues to push the boundaries of pharmaceutical innovation.

Latest Patents

Kraass's latest patents include a pharmaceutical composition containing donepezil hydrochloride, which is designed for the production of tablets through direct compression. This composition ensures that the polymorphic form I of donepezil hydrochloride remains stable during long storage periods. Another significant patent involves a rapid release irbesartan-containing pharmaceutical composition, specifically a tablet that incorporates the active ingredient along with a disintegrant featuring low-substituted hydroxypropyl cellulose. These innovations reflect his commitment to improving patient outcomes through advanced pharmaceutical formulations.

Career Highlights

Peter Kraass is currently associated with Ratiopharm GmbH, a prominent company in the pharmaceutical industry. His work at Ratiopharm has allowed him to collaborate with other talented professionals and contribute to the development of effective pharmaceutical products. His expertise in the field has positioned him as a valuable asset to the company and the industry at large.

Collaborations

Kraass has worked alongside notable colleagues such as Julia Schulze Nahrup and Frank Muskulus. These collaborations have fostered an environment of innovation and creativity, leading to the successful development of new pharmaceutical compositions.

Conclusion

Peter Kraass exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through his patents and collaborations highlight his dedication to advancing medical science and improving therapeutic options for patients.